Blander J Magarian, Longman Randy S, Iliev Iliyan D, Sonnenberg Gregory F, Artis David
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, New York, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, New York, USA.
Nat Immunol. 2017 Jul 19;18(8):851-860. doi: 10.1038/ni.3780.
The study of the intestinal microbiota has begun to shift from cataloging individual members of the commensal community to understanding their contributions to the physiology of the host organism in health and disease. Here, we review the effects of the microbiome on innate and adaptive immunological players from epithelial cells and antigen-presenting cells to innate lymphoid cells and regulatory T cells. We discuss recent studies that have identified diverse microbiota-derived bioactive molecules and their effects on inflammation within the intestine and distally at sites as anatomically remote as the brain. Finally, we highlight new insights into how the microbiome influences the host response to infection, vaccination and cancer, as well as susceptibility to autoimmune and neurodegenerative disorders.
肠道微生物群的研究已开始从对共生群落中个体成员的编目,转向了解它们在健康和疾病状态下对宿主生物体生理学的贡献。在此,我们综述了微生物组对从上皮细胞、抗原呈递细胞到固有淋巴细胞和调节性T细胞等固有免疫和适应性免疫参与者的影响。我们讨论了最近的研究,这些研究已鉴定出多种源自微生物群的生物活性分子及其对肠道内以及在解剖学上与大脑一样遥远的远端部位炎症的影响。最后,我们强调了关于微生物组如何影响宿主对感染、疫苗接种和癌症的反应,以及对自身免疫性和神经退行性疾病易感性的新见解。